Relapse Prevention With Varenicline

PHASE4CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
RecurrenceSmoking CessationSubstance-Related Disorders
Interventions
DRUG

Varenicline

Varenicline given twice a day or five weeks.

DRUG

Placebo

Placebo given twice a day or five weeks.

Trial Locations (1)

21224

Behavioral Pharmacology Research Unit, Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT00944554 - Relapse Prevention With Varenicline | Biotech Hunter | Biotech Hunter